2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH DENA BATTLE
Patient Perspectives on Cytoreductive Nephrectomy after the CARMENA Trial

VIEW ALL ASCO GU 2019 VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH OLIVER SARTOR
Overall Survival Benefit and Racial Disparities in African American Men with Metastatic Prostate Cancer

VIEW ALL PCF VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH KARIM FIZAZI
ARAMIS - Efficacy and Safety of Darolutamide in nmCRPC

VIEW ALL ASCO GU 2019 VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH JAMES GULLEY
Immunotherapy Across Genitourinary Malignancies

VIEW ALL ASCO GU 2019 VIDEOS

Featured Videos

GU Cancers Symposium 2014 - Everolimus as second-line therapy for metastatic renal cell carcinoma after one previous VEGF-targeted therapy: Final results of the noninterventional change study - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Peter J. Goebell, Ulrich Kube, Michael Staehler, Christian Doehn, Thomas Steiner, Manfred Kindler, Edwin Herrmann, Jan Janssen, Steffen Weikert, Michael Thomas Scheffler, Joerg Schmitz, Friedrich Overkamp, Gernot Guderian, Michael Albrecht, and Lothar Bergmann at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 goebell Poster thumb

Department of Urology, Friedrich-Alexander University Erlangen, Erlangen, Germany; Private Practice for Oncology, Chemnitz, Germany; Department of Urology, University of Munich, Munich, Germany; Urologikum Lübeck, Lübeck, Germany; Helios-Klinikum Erfurt, Klinik für Urologie, Erfurt, Germany; Private Practice for Oncology, Berlin, Germany; Department of Urology, University of Münster, Münster, Germany; Private Practice for Oncology, Westerstede, Germany; Charité Campus Mitte, Berlin, Germany; Praxis Dr. Scheffler, Zwickau, Germany; Kliniken der Stadt Köln Merheim, Cologne, Germany; Praxis und Tagesklinik für Internistische Onkologie, Recklinghausen, Germany; Novartis Pharma GmbH, Nuermberg, Germany; Department Drug Safety & Epidemiology, Novartis Pharma GmbH, Nuremberg, Germany; Klinikum der Johann-Wolfgang-Goethe Universität, Medizinische Klinik III, Tumorzentrum Rhein-Main,, Frankfurt/Main, Germany

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 3 Issue 4

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe